BIOSEED

Pharmaceuticals for the repair, replacement and regeneration of deficient tissue and organs; biomedical preparations, biotechnological preparations, and biomedical preparations produced and modified by genetic engineering, in particular preparations of biological tissue intended for subsequent implantation, namely, bones, bone replacements, cartilage replacements, vessel replacements, tissue replacements, and fatty tissue replacements, all comprising living tissue; surgical implants comprising living tissue; living tissue, cells and molecules produced in vitro for replacing and/or supporting the function of absent or injured body parts; products of tissue engineering, in particular organ replacement products, namely, tissue replacement products comprising living tissue; and biological tissue intended for subsequent implantation, namely, bones, bone replacements, cartilage replacements, vessel replacements, tissue replacements, and fatty tissue replacements, all comprising living tissue

Surgical implants and transplants comprising artificial material; and sets for the uptake and transport of tissue probes, said kits comprising a temperature controlled transport box, sterile plastic tubes containing an antibiotic buffer, transport solution, cooling and/or freezing elements, labels, monovettes for blood samples, and wrapping material

research, development and consultancy in the field of biomedicine and cell culture technology; services in the field of tissue engineering; cell cultivating; cultivating of implants and transplants; services of a cell laboratory, particularly in vitro production of living tissue, cells and/or molecules for replacing and/or supporting the function of absent or injured body parts